Formononetin protects TBI rats against neurological lesions and the underlying mechanism

Journal of the Neurological Sciences

Volumn 338, Issue 1-2, 2014, Pages 112-117

  Li, Zhengzhao ^a   Dong, Xianhong ^b   Zhang, Jianfeng ^a   Zeng, Guang ^a   Zhao, Huimin ^a   Liu, Yun ^a   Qiu, Rubiao ^c   Mo, Linjian ^a   Ye, Yu ^a  

^a FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIVERSITY   (China)

^b XINXIANG MEDICAL UNIVERSITY   (China)

^c Guangxi Matemal and Child Health Hospital   (China)

Author keywords

Formononetin; Inflammation; Neuroprotection; Oxidative stress; Rat; Traumatic brain injury

Indexed keywords

CYCLOOXYGENASE 2; FORMONONETIN; GLUTATHIONE PEROXIDASE; INTERLEUKIN 6; MALONALDEHYDE; MESSENGER RNA; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR NRF2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DAMAGE; BRAIN TISSUE; CONTROLLED STUDY; DRUG DOSE COMPARISON; HYDROCEPHALUS; MALE; NERVE CELL LESION; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RAT MODEL; TRAUMATIC BRAIN INJURY;

FORMONONETIN; INFLAMMATION; NEUROPROTECTION; OXIDATIVE STRESS; RAT; TRAUMATIC BRAIN INJURY;

ANIMALS; BRAIN INJURIES; CYCLOOXYGENASE 2; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GA-BINDING PROTEIN TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION; GLUTATHIONE; INTERLEUKIN-6; ISOFLAVONES; MALE; MALONDIALDEHYDE; NERVOUS SYSTEM DISEASES; NEUROPROTECTIVE AGENTS; RATS; RATS, WISTAR; RNA, MESSENGER; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84896723300     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2013.12.027     Document Type: Article

References (35)

1. J. Larsson, A. Björkdahl, E. Esbjörnsson, and K.S. Sunnerhagen Factors affecting participation after traumatic brain injury J Rehabil Med 45 2013 765 770
2. M. Levy, A. Berson, T. Cook, N. Bollegala, E. Seto, and S. Tursanski et al. Treatment of agitation following traumatic brain injury: a review of the literature NeuroRehabilitation 20 2005 279 306
3. J.D. Corrigan, A.W. Selassie, and J.A. Orman The epidemiology of traumatic brain injury J Head Trauma Rehabil 25 2010 72 80
4. J.V. Rosenfeld, A.I. Maas, P. Bragge, M.C. Morganti-Kossmann, G.T. Manley, and R.L. Gruen Early management of severe traumatic brain injury Lancet 380 2012 1088 1098
5. C.F. Muccio, M. De Simone, G. Esposito, E. De Blasio, C. Vittori, and A. Cerase Reversible post-traumatic bilateral extensive restricted diffusion of the brain. A case study and review of the literature Brain Inj 23 2009 466 472
6. T.M. Andriessen, B. Jacobs, and P.E. Vos Clinical characteristics and pathophysiological mechanisms of focal and diffuse traumatic brain injury J Cell Mol Med 14 2010 2381 2392
7. M. Maegele Coagulopathy after traumatic brain injury: incidence, pathogenesis, and treatment options Transfusion 53 2013 28 37
8. S. Parikh, M. Koch, and R.K. Narayan Traumatic brain injury Int Anesthesiol Clin 45 2007 119 135
9. Y.L. Lo, and W. Wang Formononetin potentiates epirubicin-induced apoptosis via ROS production in HeLa cells in vitro Chem Biol Interact 205 2013 188 197
10. J. Chen, and L. Sun Formononetin-induced apoptosis by activation of Ras/p38 mitogen-activated protein kinase in estrogen receptor-positive human breast cancer cells Horm Metab Res 44 2012 943 948
11. H. Mu, Y.H. Bai, S.T. Wang, Z.M. Zhu, and Y.W. Zhang Research on antioxidant effects and estrogenic effect of formononetin from Trifolium pratense (red clover) Phytomedicine 16 2009 314 319
12. H.D. Liu, W. Li, Z.R. Chen, Y.C. Hu, D.D. Zhang, and W. Shen et al. Expression of the NLRP3 inflammasome in cerebral cortex after traumatic brain injury in a rat model Neurochem Res 38 2013 2072 2083
13. A. Mahmood, D. Lu, L. Wang, Y. Li, M. Lu, and M. Chopp Treatment of traumatic brain injury in female rats with intravenous administration of bone marrow stromal cells Neurosurgery 49 2001 1196 1203
14. J.J. Davis, K.H. Walter, K.M. Chard, R.B. Parkinson, and W.S. Houston Treatment adherence in cognitive processing therapy for combat-related PTSD with history of mild TBI Rehabil Psychol 58 2013 36 42
15. N.A. Lannin, A. Cusick, R. McLachlan, and J. Allaous Observed recovery sequence in neurobehavioral function after severe traumatic brain injury Am J Occup Ther 67 2013 543 549
16. J. Elliott, and M. Smith The acute management of intracerebral hemorrhage: a clinical review Anesth Analg 110 2010 1419 1427
17. L.L. Hurley, and Y. Tizabi Neuroinflammation, neurodegeneration, and depression Neurotox Res 23 2013 131 144
18. L. Marošová, P. Neradil, and N. Zilka How can viruses influence the neuroinflammation and neurodegeneration in the aged human brain Acta Virol 57 2013 273 281
19. K.A. Frankola, N.H. Greig, W. Luo, and D. Tweedie Targeting TNF-α to elucidate and ameliorate neuroinflammation in neurodegenerative diseases CNS Neurol Disord Drug Targets 10 2011 391 403
20. X. Yang, C. Luo, J. Cai, D.W. Powell, D. Yu, and M.H. Kuehn et al. Neurodegenerative and inflammatory pathway components linked to TNF-α/TNFR1 signaling in the glaucomatous human retina Invest Ophthalmol Vis Sci 52 2011 8442 8454
21. A.L. Groeger, C. Cipollina, M.P. Cole, S.R. Woodcock, G. Bonacci, and T.K. Rudolph et al. Cyclooxygenase-2 generates anti-inflammatory mediators from omega-3 fatty acids Nat Chem Biol 6 2010 433 441
22. B. Roschek Jr., R.C. Fink, D. Li, M. McMichael, C.M. Tower, and R.D. Smith et al. Pro-inflammatory enzymes, cyclooxygenase 1, cyclooxygenase 2, and 5-lipooxygenase, inhibited by stabilized rice bran extracts J Med Food 12 2009 615 623
23. D. Cosentino-Gomes, N. Rocco-Machado, and J.R. Meyer-Fernandes Cell signaling through protein kinase C oxidation and activation Int J Mol Sci 13 2012 10697 10721
24. S.I. Liochev Reactive oxygen species and the free radical theory of aging Free Radic Biol Med 60 2013 1 4
25. C. Guerra-Araiza, A.L. Álvarez-Mejía, S. Sánchez-Torres, E. Farfan-García, R. Mondragón-Lozano, and R. Pinto-Almazán et al. Effect of natural exogenous antioxidants on aging and on neurodegenerative diseases Free Radic Res 47 2013 451 462
26. I. Dokic, C. Hartmann, C. Herold-Mende, and A. Régnier-Vigouroux Glutathione peroxidase 1 activity dictates the sensitivity of glioblastoma cells to oxidative stress Glia 60 2012 1785 1800
27. G. Torsdottir, J. Kristinsson, J. Snaedal, S. Sveinbjörnsdó ttir, G. Gudmundsson, and S. Hreidarsson et al. Case-control studies on ceruloplasmin and superoxide dismutase (SOD1) in neurodegenerative diseases: a short review J Neurol Sci 299 2010 51 54
28. D. Weismann, K. Hartvigsen, N. Lauer, K.L. Bennett, H.P. Scholl, and P. Charbel Issa et al. Complement factor H binds malondialdehyde epitopes and protects from oxidative stress Nature 478 2011 76 81
29. O. Ates, S. Cayli, E. Altinoz, I. Gurses, N. Yucel, and M. Sener et al. Neuroprotection by resveratrol against traumatic brain injury in rats Mol Cell Biochem 294 2007 137 144
30. F. Dehghan, M. Khaksari Hadad, G. Asadikram, H. Najafipour, and N. Shahrokhi Effect of melatonin on intracranial pressure and brain edema following traumatic brain injury: role of oxidative stresses Arch Med Res 44 2013 251 258
31. B.R. Imhoff, and J.M. Hansen Extracellular redox status regulates Nrf2 activation through mitochondrial reactive oxygen species Biochem J 424 2009 491 500
32. T. Yamamoto, T. Suzuki, A. Kobayashi, J. Wakabayashi, J. Maher, and H. Motohashi et al. Physiological significance of reactive cysteine residues of Keap1 in determining Nrf2 activity Mol Cell Biol 28 2008 2758 2770
33. S. Freigang, F. Ampenberger, G. Spohn, S. Heer, A.T. Shamshiev, and J. Kisielow et al. Nrf2 is essential for cholesterol crystal-induced inflammasome activation and exacerbation of atherosclerosis Eur J Immunol 41 2011 2040 2051
34. H. Saito Toxico-pharmacological perspective of the Nrf2-Keap1 defense system against oxidative stress in kidney diseases Biochem Pharmacol 85 2013 865 872
35. K. Gupta, S. Chandran, and G.E. Hardingham Human stem cell-derived astrocytes and their application to studying Nrf2-mediated neuroprotective pathways and therapeutics in neurodegeneration Br J Clin Pharmacol 75 2013 907 918